FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022671185> ?p ?o ?g. }

• W2022671185 endingPage "972" @default.
• W2022671185 startingPage "971" @default.
• W2022671185 abstract "Drug-induced reactions are not well described in paediatric literature, less so in the newborn [1]. Piperacillin/tazobactam is a combination of an extended-spectrum penicillin, piperacillin and the α-lactamase inhibitor tazobactam commonly marketed by Wyeth (Maidenhead, UK) under the trade name Tazocin® or Zosyn®[2]. This broad spectrum antibiotic is used by neonatalogists to treat sepsis as a second- or third-line antibiotic. There are no reported data of skin reactions as a result of piperacillin/tazobactam in neonatal literature [3, 4]. In adults, the most commonly reported adverse events in clinical trials of piperacillin/tazobactam plus an aminoglycoside have included diarrhoea (17.6%), fever (2.7%), vomiting (2.7%), urinary tract infection (2.7%) and rash (2.3%). Piperacillin/tazobactam, like other penicillins, can also cause reversible agranulocytosis [2, 5]. A 27 + 4-week male infant weighing 0.936 kg was born vaginally to a 16-year-old primigravida following onset of premature labour. There was no evidence of chorioamnionitis. The baby was transferred ex utero to our Neonatal Intensive Care Unit soon after delivery. One dose of steroid had been given 6 h before the delivery and one dose of curosurf at birth. His Apgar score at 5 min was 8. He was extubated on the second day onto continuous positive airway pressure. He developed a septic illness when he was 26 days old and required re-ventilation. He was started on piperacillin/tazobactam (90 mg kg−1 12 hourly) and gentamycin 4 mg kg−1 once a day, as previous skin swabs had grown lactose fermenting coliforms. After his first two doses of piperacillin/tazobactam the baby developed a peeling exanthema mainly involving his hands and soles of his feet, which later spread to involve the rest of his body to a lesser degree. The piperacillin/tazobactam was stopped in favour of meropenem after 48 h because of the possibility that this was a drug reaction. No staphylococcus was isolated from any skin or blood cultures. During this episode, his blood pressure was stable and no inotropes were needed. At the same time, he developed a coagulopathy associated with neutropenia and thrombocytopenia managed with transfusions of platelets, blood and plasma. After stopping the piperacillin/tazobactam, the skin condition improved over the following week; he developed generalized exfoliation revealing normal underlying skin. Drug reactions are rarely described in the neonatal literature. In adult literature, piperacillin/tazobactam has been described to cause a dermatological reaction. We report a case of a 27-week infant who was treated with piperacillin/tazobactam for a septic episode, following which he developed a severe exanthema and agranulocytosis. Although staphylococcal scalded skin was a differential diagnosis in our patient, we failed to isolate any staphylococcus from blood or surface (including nose) swabs. It is important to consider drug reactions in neonatology where the use of antibiotics is rife. As there are scant safety and efficacy data for use of many drugs used in neonatology, there is a need to be suspicious of skin reactions in neonates, as these may be due to drugs. We would encourage neonatologists to consider adverse drug reactions and report them in order to gain more information on this topic." @default.
• W2022671185 created "2016-06-24" @default.
• W2022671185 creator A5014293421 @default.
• W2022671185 creator A5026171250 @default.
• W2022671185 creator A5070527863 @default.
• W2022671185 date "2008-06-01" @default.
• W2022671185 modified "2023-10-14" @default.
• W2022671185 title "Suspected drug reaction with piperacillin/tazobactam, in a premature infant" @default.
• W2022671185 cites W2053078714 @default.
• W2022671185 cites W2063215767 @default.
• W2022671185 cites W2131596979 @default.
• W2022671185 cites W2135991107 @default.
• W2022671185 doi "https://doi.org/10.1111/j.1365-2125.2008.03105.x" @default.
• W2022671185 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2485230" @default.
• W2022671185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18307542" @default.
• W2022671185 hasPublicationYear "2008" @default.
• W2022671185 type Work @default.
• W2022671185 sameAs 2022671185 @default.
• W2022671185 citedByCount "3" @default.
• W2022671185 countsByYear W20226711852017 @default.
• W2022671185 crossrefType "journal-article" @default.
• W2022671185 hasAuthorship W2022671185A5014293421 @default.
• W2022671185 hasAuthorship W2022671185A5026171250 @default.
• W2022671185 hasAuthorship W2022671185A5070527863 @default.
• W2022671185 hasBestOaLocation W20226711851 @default.
• W2022671185 hasConcept C187212893 @default.
• W2022671185 hasConcept C2777629866 @default.
• W2022671185 hasConcept C2777637488 @default.
• W2022671185 hasConcept C2777858937 @default.
• W2022671185 hasConcept C2778193466 @default.
• W2022671185 hasConcept C2778266534 @default.
• W2022671185 hasConcept C2778376644 @default.
• W2022671185 hasConcept C2779234561 @default.
• W2022671185 hasConcept C42219234 @default.
• W2022671185 hasConcept C523546767 @default.
• W2022671185 hasConcept C54355233 @default.
• W2022671185 hasConcept C71924100 @default.
• W2022671185 hasConcept C86803240 @default.
• W2022671185 hasConceptScore W2022671185C187212893 @default.
• W2022671185 hasConceptScore W2022671185C2777629866 @default.
• W2022671185 hasConceptScore W2022671185C2777637488 @default.
• W2022671185 hasConceptScore W2022671185C2777858937 @default.
• W2022671185 hasConceptScore W2022671185C2778193466 @default.
• W2022671185 hasConceptScore W2022671185C2778266534 @default.
• W2022671185 hasConceptScore W2022671185C2778376644 @default.
• W2022671185 hasConceptScore W2022671185C2779234561 @default.
• W2022671185 hasConceptScore W2022671185C42219234 @default.
• W2022671185 hasConceptScore W2022671185C523546767 @default.
• W2022671185 hasConceptScore W2022671185C54355233 @default.
• W2022671185 hasConceptScore W2022671185C71924100 @default.
• W2022671185 hasConceptScore W2022671185C86803240 @default.
• W2022671185 hasIssue "6" @default.
• W2022671185 hasLocation W20226711851 @default.
• W2022671185 hasLocation W20226711852 @default.
• W2022671185 hasLocation W20226711853 @default.
• W2022671185 hasLocation W20226711854 @default.
• W2022671185 hasOpenAccess W2022671185 @default.
• W2022671185 hasPrimaryLocation W20226711851 @default.
• W2022671185 hasRelatedWork W2041947275 @default.
• W2022671185 hasRelatedWork W2070526767 @default.
• W2022671185 hasRelatedWork W2165488979 @default.
• W2022671185 hasRelatedWork W2316290761 @default.
• W2022671185 hasRelatedWork W2348497797 @default.
• W2022671185 hasRelatedWork W2375816003 @default.
• W2022671185 hasRelatedWork W2383028918 @default.
• W2022671185 hasRelatedWork W2402494363 @default.
• W2022671185 hasRelatedWork W2626144677 @default.
• W2022671185 hasRelatedWork W4313637959 @default.
• W2022671185 hasVolume "65" @default.
• W2022671185 isParatext "false" @default.
• W2022671185 isRetracted "false" @default.
• W2022671185 magId "2022671185" @default.
• W2022671185 workType "article" @default.